![]() |
|
Abstract Links |
|
Conley KE, Jubrias SA, Esselman PC. Oxidative capacity and ageing in human muscle. J Physiol. 2000;Jul 1;526Pt 1:203-210. Department of Radiology, University of Washington Medical Center, Seattle, WA 98195-7115, USA. kconley@u.washington.edu This study determined the decline in oxidative capacity per volume of human vastus lateralis muscle between nine adult (mean age 38.8 years) and 40 elderly (mean age 68.8 years) human subjects (age range 25-80 years). We based our oxidative capacity estimates on the kinetics of changes in creatine phosphate content ([PCr]) during recovery from exercise as measured by (31)P magnetic resonance (MR) spectroscopy. A matched muscle biopsy sample permitted determination of mitochondrial volume density and the contribution of the loss of mitochondrial content to the decline in oxidative capacity with age. The maximal oxidative phosphorylation rate or oxidative capacity was estimated from the PCr recovery rate constant (k(PCr)) and the [PCr] in accordance with a simple electrical circuit model of mitochondrial respiratory control. Oxidative capacity was 50 % lower in the elderly vs. the adult group (0.61 +/- 0.04 vs. 1.16 +/- 0.147 mM ATP s(-1)). Mitochondrial volume density was significantly lower in elderly compared with adult muscle (2.9 +/- 0.15 vs. 3.6 +/- 0.11 %). In addition, the oxidative capacity per mitochondrial volume (0.22 +/- 0.042 vs. 0.32 +/- 0.015 mM ATP (s %)(-1)) was reduced in elderly vs. adult subjects. This study showed that elderly subjects had nearly 50 % lower oxidative capacity per volume of muscle than adult subjects. The cellular basis of this drop was a reduction in mitochondrial content, as well as a lower oxidative capacity of the mitochondria with age.
2006 TSI Health Sciences. Specifications | Research | Licensing | Where
to Buy | About
TSI | Contact
|
A Prospective, Randomized, Double Blind Study to Evaluate the Effects of Orally... A randomized, double-blind, placebo controlled triphosphate... Adenosine and cardioprotection in the diseased heart... Adenosine-mediated cardioprotection in the aging myocardium... Antihypertensive effect of all-cis-5,8,11,14,17... ATP flux through creatine kinase in the normal, stressed... ATP stimulates glucose transport through activation of P2... Beneficial effects of adenosine triphosphate on nutritional... Cardiovascular and pulmonary response to oral administration... Circulating ATP-induced vasodilatation overrides sympathetic... Clinical observation of oral adenosine triposthate in treating.... Diabetes mellitus and subjects' ageing: a study on the ATP... Effect of adenosine triphosphate and some derivatives on... Erythrocyte and the regulation of human skeletal muscle... Exogenous magnesium chloride-adenosine triphosphate... Impaired release of ATP from red blood cells of humans... Interstitial ATP and norepinephrine concentrations in... Intracoronary administration of adenosine triphosphate... Lung epithelial cells release ATP during ozone exposure... Measuring the contribution of pharmacological treatment... Mechanism of vasodilation to adenosine in coronary... Oxidative capacity and ageing in human muscle. Pretreatment of human myocardium with adenosine... Randomized clinical trial adenosine 5'-triphosphate... Reconditioning with ischemia or adenosine protects... Red blood cell regulation of microvascular tone through... Signaling pathways involved in adenosine triphosphate... Systemic hypoxia elevates skeletal muscle interstitia... The erythrocyte as a regulator of vascular tone. The hypotensive effect of docosahexaenoic acid... The T-tubule membrane ATP-operated P2X4 recepto...
|